Vitamin D action: Lessons learned from hereditary 1,25-dihydroxyvitamin-D- resistant rickets patients

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 6, 2012, Pages 452-459

  Tiosano, Dov ^a   Gepstein, Vardit ^b  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

intestinal calcium absorption; rennin angiotensin system; vitamin D receptor

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D RECEPTOR;

ALOPECIA; BONE DENSITY; BONE GROWTH; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR EFFECT; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; FAMILIAL HYPOPHOSPHATEMIC RICKETS; GENE DELETION; GENE MUTATION; GENETIC CODE; HEREDITARY 1,25 DIHYDROXYVITAMIN D RESISTANT RICKETS; HORMONE RESISTANCE; HUMAN; HYPOCALCEMIA; HYPOPHOSPHATEMIA; NONHUMAN; OSTEOMALACIA; PUBERTY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SECONDARY HYPERPARATHYROIDISM; TREATMENT INDICATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AGE FACTORS; ANIMALS; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; INTESTINAL ABSORPTION; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D;

EID: 84869751944     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835a3415     Document Type: Review

References (41)

1. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012; 97:1146-1152.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-1930.
3. Malloy PJ, Feldman D. Genetic disorders and defects in vitamin d action. Endocrinol Metab Clin North Am 2010; 39:333-346; table of contents.
4. Tiosano D, Weisman Y, Hochberg Z. The role of the vitamin D receptor in regulating vitamin D metabolism: a study of vitamin D-dependent rickets, type II. J Clin Endocrinol Metab 2001; 86:1908-1912.
5. Farese S. The hungry bone syndrome: an update. Ther Umsch 2007; 64:277-280.
6. Hughes MR, Malloy PJ, Kieback DG, et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988; 242:1702-1705.
7. Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 1999; 20:156-188.
8. Hewison M, Rut AR, Kristjansson K, et al. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin Endocrinol (Oxf) 1993; 39:663-670.
9. Chen H, Hewison M, Hu B, Adams JS. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci USA 2003; 100:6109-6114.
10. Bouillon R, Van Cromphaut S, Carmeliet G. Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J Cell Biochem 2003; 88:332-339.
11. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16:391-396.
12. Li YC, Bolt MJ, Cao LP, Sitrin MD. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab 2001; 281:E558-E564.
13. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 2001; 98:13324-13329.
14. Benn BS, Ajibade D, Porta A, et al. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 2008; 149:3196-3205.
15. Fujita H, Sugimoto K, Inatomi S, et al. Tight junction proteins claudin-2 and-12 are critical for vitamin D-dependent Ca2\+ absorption between enterocytes. Mol Biol Cell 2008; 19:1912-1921.
16. Kutuzova GD, Deluca HF. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties. Arch Biochem Biophys 2004; 432:152-166.
17. Fudge NJ, Kovacs CS. Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Endocrinology 2010; 151:886-895.
18. Van Cromphaut SJ, Rummens K, Stockmans I, et al. Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res 2003; 18:1725-1736.
19. Pahuja DN, DeLuca HF. Stimulation of intestinal calcium transport and bone calcium mobilization by prolactin in vitamin D-deficient rats. Science 1981; 214:1038-1039.
20. Ajibade DV, Dhawan P, Fechner AJ, et al. Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin D(3) 1alpha hydroxylase gene by prolactin. Endocrinology 2010; 151: 2974-2984.
21. Colin EM, Van Den Bemd GJ, Van Aken M, et al. Evidence for involvement of 17beta-estradiol in intestinal calciumabsorption independent of 1,25-dihydroxyvitamin D3 level in the Rat. J Bone Miner Res 1999; 14:57-64.
22. Tiosano D, Hadad S, Chen Z, et al. Calcium absorption, kinetics, bone density, and bone structure in patients with hereditary vitamin D-resistant rickets. J Clin Endocrinol Metab 2011; 96:3701-3709.
23. Lieben L, Masuyama R, Torrekens S, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 2012; 122:1803-1815.
24. Bronner F. Recent developments in intestinal calcium absorption. Nutr Rev 2009; 67:109-113.
25. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93:3927-3935.
26. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009; 6:621-630.
27. Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 2008; 52:1106-1112.
28. Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007; 104:16810-16815.
29. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
30. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288:E125-E132.
31. Aarskog D, Aksnes L, Markestad T, Rodland O. Effect of estrogen on vitamin D metabolism in tall girls. J Clin Endocrinol Metab 1983; 57:1155-1158.
32. Tiosano D, Schwartz Y, Braver Y, et al. The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res 2011; 26:2252-2260.
33. Urbina E, Alpert B, Flynn J, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008; 52:433-451.
34. Morello F, de Boer RA, Steffensen KR, et al. Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest 2005; 115:1913-1922.
35. Shi Q, Gross KW, Sigmund CD. NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension 2001; 38:332-336.
36. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55:1283-1288.
37. Silver J, Naveh-Many T, Mayer H, et al. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986; 78:1296-1301.
38. Broulik PD, Horky K, Pacovsky V. Effect of parathyroid hormone on plasma renin activity in humans. Horm Metab Res 1986; 18:490-492.
39. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-238.
40. Lavi-Moshayoff V, Wasserman G, Meir T, et al. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010; 299:F882-F889.
41. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121:4393-4408.